A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/606 (2006.01) A61K 31/13 (2006.01) A61K 31/198 (2006.01) A61P 1/00 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2553775
Inflammatory bowel diseases are represented by two idiopathic disorders, which include ulcerative colitis and Crohn's disease. Ulcerative colitis is restricted to the colon and involves uncertain and inflammation of the lining (mucosa) of the large intestine. Crohn's disease, on the other hand, can involve the mucosa of the small and/or large intestine and may involve deeper layers of the bowel wall. The present invention is a combination of 5- aminosalicylic acid and one or more antioxidants (e.g., N-acetylcysteine) for treating such inflammatory bowel diseases or other inflammatory bowel diseases.
Les maladies intestinales inflammatoires sont représentées par deux dysfonctionnements idiopathiques qui comprennent la colite ulcéreuse et la maladie de Crohn. La colite ulcéreuse se limite au colon et implique l'inflammation de la paroi (muqueuse) du gros intestin. La maladie de Crohn, d'autre part, peut concerner la muqueuse de l'intestin grêle et/ou du gros intestin, et peut concerner des couches profondes de la paroi intestinale. L'invention concerne une combinaison d'acide 5-aminosalicylique et d'un ou plusieurs antioxydants (par ex. N-acétylcystéine) pour traiter ces maladies intestinales inflammatoires ou d'autres maladies intestinales inflammatoires.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Harty Richard F.
The Board Of Regents Of The University Of Oklahoma
LandOfFree
Compositions and methods of treatment for inflammatory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of treatment for inflammatory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of treatment for inflammatory diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1910475